Anne Wojcicki Wins Bidding for 23andMe by Wallstreet Journal | June 14, 2025 2:03 am | US Markets Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a higher bid.